Matches in SemOpenAlex for { <https://semopenalex.org/work/W2614669943> ?p ?o ?g. }
- W2614669943 endingPage "186" @default.
- W2614669943 startingPage "175" @default.
- W2614669943 abstract "Attention-deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder. Systematic reviews indicate that the community prevalence globally is between 2% and 7%, with an average of around 5%. At least a further 5% of children have substantial difficulties with overactivity, inattention, and impulsivity that are just under the threshold to meet full diagnostic criteria for ADHD. Estimates of the administrative prevalence (clinically diagnosed or recorded) vary worldwide, and have been increasing over time. However, ADHD is still relatively under-recognised and underdiagnosed in most countries, particularly in girls and older children. ADHD often persists into adulthood and is a risk factor for other mental health disorders and negative outcomes, including educational underachievement, difficulties with employment and relationships, and criminality. The timely recognition and treatment of children with ADHD-type difficulties provides an opportunity to improve long-term outcomes. This Review includes a systematic review of the community and administrative prevalence of ADHD in children and adolescents, an overview of barriers to accessing care, a description of associated costs, and a discussion of evidence-based pathways for the delivery of clinical care, including a focus on key issues for two specific age groups—younger children (aged ≤6 years) and adolescents requiring transition of care from child to adult services. Attention-deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder. Systematic reviews indicate that the community prevalence globally is between 2% and 7%, with an average of around 5%. At least a further 5% of children have substantial difficulties with overactivity, inattention, and impulsivity that are just under the threshold to meet full diagnostic criteria for ADHD. Estimates of the administrative prevalence (clinically diagnosed or recorded) vary worldwide, and have been increasing over time. However, ADHD is still relatively under-recognised and underdiagnosed in most countries, particularly in girls and older children. ADHD often persists into adulthood and is a risk factor for other mental health disorders and negative outcomes, including educational underachievement, difficulties with employment and relationships, and criminality. The timely recognition and treatment of children with ADHD-type difficulties provides an opportunity to improve long-term outcomes. This Review includes a systematic review of the community and administrative prevalence of ADHD in children and adolescents, an overview of barriers to accessing care, a description of associated costs, and a discussion of evidence-based pathways for the delivery of clinical care, including a focus on key issues for two specific age groups—younger children (aged ≤6 years) and adolescents requiring transition of care from child to adult services. Barriers to medication entitlements after diagnosis of ADHD – Authors' replyWe thank John Hayden and colleagues for their helpful comments on our paper.1 We are also pleased that a resolution was found in Ireland for the particular problem that had been limiting access to care for those with attention-deficit hyperactivity disorder (ADHD). We agree that it is important to consider and address barriers to care that might exist post-diagnosis and thank them for highlighting this issue. There is considerable variation in the way that reimbursement for medications is handled within different health-care systems as well as disparity in how rules are applied for different disorders. Full-Text PDF Barriers to medication entitlements after diagnosis of ADHDKapil Sayal and colleagues1 recently reviewed the prevalence of attention deficit hyperactivity disorder (ADHD) in children and young people, care pathways, and service provision. Community prevalence is estimated to be within the range of 2·2–7·2%. Although estimates have remained stable over the past three decades, prescription rates have dramatically increased. This increase has been attributed to better awareness, improved treatment access in countries where under-diagnosis has been an issue, or perhaps emergent over-diagnosis in others. Full-Text PDF Medication accessibility after diagnosis of ADHD in Croatia – Authors' replyWe welcome Tomislav Franić and Katarina Dodig Ćurković's contribution to the discussion about access to attention-deficit hyperactivity disorder (ADHD) medication, including their views on complex administration, stigma, and public fear of abuse. Challenges in accessing ADHD services are complex and multifactorial.1 In our previous Correspondence2 regarding a Review by Kapil Sayal and colleagues1 on ADHD in children and young people, we sought to highlight an additional barrier (medication access after diagnosis), citing cases in Ireland and Croatia. Full-Text PDF" @default.
- W2614669943 created "2017-05-26" @default.
- W2614669943 creator A5048732531 @default.
- W2614669943 creator A5062787824 @default.
- W2614669943 creator A5070895823 @default.
- W2614669943 creator A5076676344 @default.
- W2614669943 creator A5079604448 @default.
- W2614669943 date "2018-02-01" @default.
- W2614669943 modified "2023-10-17" @default.
- W2614669943 title "ADHD in children and young people: prevalence, care pathways, and service provision" @default.
- W2614669943 cites W1491474309 @default.
- W2614669943 cites W1491709100 @default.
- W2614669943 cites W1526727491 @default.
- W2614669943 cites W1575253450 @default.
- W2614669943 cites W1579301150 @default.
- W2614669943 cites W1608645544 @default.
- W2614669943 cites W1923075524 @default.
- W2614669943 cites W1970405055 @default.
- W2614669943 cites W1973510512 @default.
- W2614669943 cites W1976201431 @default.
- W2614669943 cites W1980065269 @default.
- W2614669943 cites W1983030849 @default.
- W2614669943 cites W1987824576 @default.
- W2614669943 cites W1989270852 @default.
- W2614669943 cites W1991527224 @default.
- W2614669943 cites W1991871056 @default.
- W2614669943 cites W1992576609 @default.
- W2614669943 cites W1994329387 @default.
- W2614669943 cites W1996341133 @default.
- W2614669943 cites W1998071736 @default.
- W2614669943 cites W1999058928 @default.
- W2614669943 cites W1999322238 @default.
- W2614669943 cites W2007817385 @default.
- W2614669943 cites W2008105491 @default.
- W2614669943 cites W2008202873 @default.
- W2614669943 cites W2018297368 @default.
- W2614669943 cites W2018654578 @default.
- W2614669943 cites W2021849865 @default.
- W2614669943 cites W2022330640 @default.
- W2614669943 cites W2022782792 @default.
- W2614669943 cites W2029309742 @default.
- W2614669943 cites W2029699790 @default.
- W2614669943 cites W2033304004 @default.
- W2614669943 cites W2035864105 @default.
- W2614669943 cites W2037665165 @default.
- W2614669943 cites W2038797528 @default.
- W2614669943 cites W2038883203 @default.
- W2614669943 cites W2039539933 @default.
- W2614669943 cites W2047123426 @default.
- W2614669943 cites W2049068132 @default.
- W2614669943 cites W2049884384 @default.
- W2614669943 cites W2053016085 @default.
- W2614669943 cites W2057552628 @default.
- W2614669943 cites W2058365290 @default.
- W2614669943 cites W2058562698 @default.
- W2614669943 cites W2060223466 @default.
- W2614669943 cites W2066152675 @default.
- W2614669943 cites W2069615319 @default.
- W2614669943 cites W2070684312 @default.
- W2614669943 cites W2072082642 @default.
- W2614669943 cites W2072710783 @default.
- W2614669943 cites W2075977736 @default.
- W2614669943 cites W2080539811 @default.
- W2614669943 cites W2081653247 @default.
- W2614669943 cites W2088291205 @default.
- W2614669943 cites W2090324832 @default.
- W2614669943 cites W2090637421 @default.
- W2614669943 cites W2093486443 @default.
- W2614669943 cites W2095295465 @default.
- W2614669943 cites W2096848956 @default.
- W2614669943 cites W2097313248 @default.
- W2614669943 cites W2097842640 @default.
- W2614669943 cites W2099992071 @default.
- W2614669943 cites W2101290999 @default.
- W2614669943 cites W2101471020 @default.
- W2614669943 cites W2101489252 @default.
- W2614669943 cites W2101691041 @default.
- W2614669943 cites W2102388069 @default.
- W2614669943 cites W2107932685 @default.
- W2614669943 cites W2110667600 @default.
- W2614669943 cites W2110957368 @default.
- W2614669943 cites W2111086327 @default.
- W2614669943 cites W2111492595 @default.
- W2614669943 cites W2114290463 @default.
- W2614669943 cites W2115826660 @default.
- W2614669943 cites W2117239810 @default.
- W2614669943 cites W2120485268 @default.
- W2614669943 cites W2120831849 @default.
- W2614669943 cites W2121990377 @default.
- W2614669943 cites W2126271209 @default.
- W2614669943 cites W2127901933 @default.
- W2614669943 cites W2130572724 @default.
- W2614669943 cites W2130742531 @default.
- W2614669943 cites W2131099228 @default.
- W2614669943 cites W2131972799 @default.
- W2614669943 cites W2133565704 @default.
- W2614669943 cites W2137067861 @default.
- W2614669943 cites W2139945474 @default.